Author

Onur Osman Şeker

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognostic value of the C-reactive protein–albumin–lymphocyte index for predicting one-year mortality in acute pulmonary embolism

Acute pulmonary embolism (APE) is associated with substantial mortality despite advances in diagnosis and treatment. Biomarkers reflecting inflammation, immune status, and nutritional reserve may improve risk stratification. This study aimed to evaluate the prognostic significance of the C-reactive protein–albumin–...

Abdulkadir Kara, Güney Erdoğan, Serkan Sivri et al. · Frontiers in Cardiovascular... · 0 citations

Open access Sep 2026

Long‐Term Renal Function and Clinical Outcomes of Sacubitril/Valsartan in HFrEF and Stage 3–4 Chronic Kidney Disease: A 24‐Month Single‐Centre Cohort

Stage 3–4 chronic kidney disease (CKD) is common in heart failure with reduced ejection fraction (HFrEF) but remains underrepresented in angiotensin receptor–neprilysin inhibitor (ARNI) trials, fostering reluctance to initiate sacubitril/valsartan (S/V).

Fatih Akkaya, Onur Osman Şeker, E. Turkmen et al. · Clinical Cardiology · 0 citations